Diabetic retinopathy: An Indian perspective

Indian Journal of Medical Research

Volumn 125, Issue 3, 2007, Pages 297-310

  Rema, M ^a   Pradeepa, R ^a  

^a MADRAS DIABETES RESEARCH FOUNDATION   (India)

Author keywords

Diabetic retinopathy; Indian subjects; Prevalence; Risk factors; Type 2 diabetes mellitus

Indexed keywords

ACETYLSALICYLIC ACID; CANDESARTAN HEXETIL; CURCUMIN; GLUCOSE; LIPID; MIDOSTAURIN; OCTREOTIDE; PERINDOPRIL; PONALRESTAT; RUBOXISTAURIN; TICLOPIDINE; TOLRESTAT;

ALCOHOL CONSUMPTION; ANEMIA; ARTERY INTIMA PROLIFERATION; ATHEROSCLEROSIS; CELL PROLIFERATION; DIABETES MELLITUS; DIABETIC MICROANGIOPATHY; DIABETIC RETINOPATHY; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE DURATION; DISEASE PREDISPOSITION; ENDOTHELIUM CELL; GLUCOSE BLOOD LEVEL; HEREDITY; HUMAN; HYPERGLYCEMIA; HYPERLIPIDEMIA; HYPERTENSION; IN VIVO STUDY; INDIA; KIDNEY DISEASE; LASER COAGULATION; LIPID BLOOD LEVEL; LOW LEVEL LASER THERAPY; MICROANGIOPATHY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OXIDATIVE STRESS; PREGNANCY; PREVALENCE; PUBLIC HEALTH; RETINA EXAMINATION; REVIEW; RISK FACTOR; RISK REDUCTION; SCREENING TEST; VISUAL ACUITY; VISUAL DISORDER;

ANGIOGENESIS INHIBITORS; ANTICOAGULANTS; DIABETIC RETINOPATHY; HUMANS; INDIA; PREVALENCE; RURAL POPULATION; URBAN POPULATION;

EID: 34249299766     PISSN: 09715916     EISSN: 09715916     Source Type: Journal    
DOI: None     Document Type: Review

References (96)

1. Aiello LP, Gardner TW, King GL, Blankenship G, Cavallerano JD, Ferris FL 3rd, et al. Diabetic retinopathy. Diabetes Care 1998; 21: 143-56.
2. Klein R, Klein BE, Moss SE, Davis MD, DeMets DL. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol 1984; 102: 520-6.
3. Klein R, Klein BEK, Moss SE, Davis MD, DeMets DL. The Wisconsin epidemiologic study of diabetic retinopathy III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol 1984; 102: 527-32.
4. Klein R, Klein BE, Moss SE. Visual impairment in diabetes. Ophthalmology 1984; 91: 1-9.
5. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes, estimates for the year 2000 and projections for 2030. Diabetes Care 2004; 27: 1047-53.
6. Abrahamian H, Hornlein B, Gurdet C, Willinger C, Zaruba E, Irsigler K. Insulin-dependent diabetes mellitus:"EURODIAB IDDM Complications Study"-results from the Vienna center. Wien Klin Wochenschr 1994; 106: 136-40.
7. Mohan R, Mohan V, Ramachandran A, Viswanathan M. Retinopathy in insulin dependent diabetes mellitus (IDDM) in south India. J Assoc Physicians India 1989; 37: 370-3.
8. Rema M, Mohan V. Retinopathy at diagnosis among young Asian diabetic patients- ASDIAB Study Group. Diabetes 2002; 51 (Suppl 2): A206-7.
9. Rema M, Ponnaiya M, Mohan V. Prevalence of retinopathy in non insulin dependent diabetes mellitus at a diabetes centre in southern India. Diabetes Res Clin Pract 1996; 34: 29-36.
10. Rema M, Premkumar S, Anitha B, Deepa R, Pradeepa R, Mohan V. Prevalence of diabetic retinopathy in urban India: The Chennai Urban Rural Epidemiology Study (CURES) Eye Study, I. Invest Ophthalmol Vis Sci 2005; 46: 2328-33.
11. Deepa M, Pradeepa R, Rema M, Mohan A, Deepa R, Shanthirani S, et al. The Chennai Urban Rural Epidemiology Study (CURES) - study design and Methodology (Urban component) (CURES - 1). J Assoc Physicians India 2003; 51: 863-70.
12. Dandona L, Dandona R, Naduvilath TJ, McCarty CA, Rao GN. Population based assessment of diabetic retinopathy in an urban population in southern India. Br J Ophthal 1999; 83: 937-40.
13. Narendran V, John RK, Raghuram A, Ravindran RD, Nirmalan PK, Thulasiraj RD. Diabetic retinopathy among self reported diabetics in southern India: a population based assessment. Br J Ophthalmol 2002; 86: 1014-8.
14. Rema M, Shanthirani CS, Deepa R, Mohan V. Prevalence of diabetic retinopathy in a selected South Indian Population - The Chennai Urban Population Study (CUPS). Diabetes Res Clin Pract 2000; 50: S252.
15. Connolly V, Unwin N, Sherriff P, Bilous R, Kelly W. Diabetes, prevalence and socioeconomic status: a population based study showing increased prevalence of Type 2 diabetes in the deprived areas. J Epidemiol Commun Health 2000; 54: 173-7.
16. Harris MI. Undiagnosed NIDDM: clinical and public health issues. Diabetes Care 1993; 16: 642-52.
17. Rema M, Deepa R, Mohan V. Prevalence of retinopathy at diagnosis among Type 2 diabetic patients attending a diabetic centre in South India. Br J Ophthalmol 2000; 84: 1058-60.
18. Ramachandran A, Snehalatha C, Vijay V, Viswanathan M. Diabetic retinopathy at the time of diagnosis of NIDDM in south Indian subjects. Diabetes Res Clin Pract 1996; 32: 111-4.
19. Kohner EM, Aldington SJ, Stratton IM, Manley SE, Holman RR, Matthews DR, et al. Diabetic retinopathy at diagnosis of non insulin dependent diabetes mellitus and associated risk factors. United Kingdom Prospective Diabetes Study, 30. Arch Ophthalmol 1998: 116: 297-303.
20. Harris MI, Klein R, Welborn TA, Knuiman MW. Onset of NIDDM occurs at least 4-7 years before clinical diagnosis. Diabetes Care 1992; 15: 815-9.
21. Owens DR, Volund E, Jones D, Shannon AG, Jones IR, Birtwell AJ, et al. Retinopathy in newly presenting non insulin dependent (type 2) diabetic patients. Diabetes Res Clin Pract 1988; 9: 59-65.
22. Klein R, Klein BEK, Moss SE, Linton KL. The Beaver Dam study: retinopathy in adults with newly discovered and previously diagnosed diabetes mellitus. Ophthalmology 1992; 99: 58-62.
23. Varma R, Torres M, Pena F, Klein R, Azen SP, Los Angeles Latino Eye Study Group Prevalence of diabetic retinopathy in adult Latinos: the Los Angeles Latino eye study. Ophthalmology 2004; 111: 1298-306.
24. Broadbent DM, Scott JA, Vora JP, Harding SP. Prevalence of diabetic eye disease in an inner city population: the Liverpool Diabetic Eye Study. Eye 1999; 13: 160-5.
25. Leske MC, Wu SY, Hyman L, Li X, Hennis A, Connell AM, et al. Diabetic retinopathy in a black population: the Barbados Eye Study. Ophthalmology 1999; 106: 1893-9.
26. Mitchell P, Smith W, Wang JJ, Attebo K. Prevalence of diabetic retinopathy in an older community: the Blue Mountains Eye Study. Ophthalmology 1998; 105: 406-11.
27. Chen MS, Kao CS, Chang CJ, Wu TJ, Fu CC, Chen CJ, et al. Prevalence and risk factors of diabetic retinopathy among noninsulin-dependent diabetic subjects. Am J Ophthalmol 1992; 114: 723-30.
28. Klein R, Klein BE, Moss SE, Linton KL. The Beaver Dam Eye Study. Retinopathy in adults with newly discovered and previously diagnosed diabetes mellitus. Ophthalmology 1992; 99: 58-62.
29. The Eye Diseases Prevalence Research Group. The prevalence of diabetic retinopathy among adults in the United States. Arch Ophthalmol 2004; 122: 552-63.
30. Agardh E, Agardh CD. Diabetic retinopathy. In: Defronzo RA, Ferrannini E, Keen H, Zimmet P, editors. International textbook of diabetes mellitus. 3rd ed. Vol. 2. Chichester, England: John Wiley; 2004 p. 1187-206.
31. Balasubramanyam M, Rema M, Premanand C. Biochemical and molecular mechanisms of diabetic retinopathy. Curr Sci 2002; 83: 1506-14.
32. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001; 414: 813-20.
33. Aiello LM, Rand LI, Briones JC, Wafai MZ, Sebestyen JG. Diabetic retinopathy in Joslin Clinic patients with adult-onset diabetes. Ophthalmology 1981; 88: 619-23.
34. Klein R, Davis MD, Moss SE, Klein BE, DeMets DL. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. A comparison of retinopathy in younger and older onset diabetic persons. Adv Exp Med Biol 1985; 189: 321-35.
35. Klein R, Klein BE, Moss SE, Cruickshanks KJ. The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XVII. The 14-year incidence and progression of diabetic retinopathy and associated risk factors in Type 1 diabetes. Ophthalmology 1998; 105: 1801-15.
36. The DCCT Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977-86.
37. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837-53.
38. Rema M, Sujatha P, Pradeepa R. Visual outcomes of panretinal photocoagulation in diabetic retinopathy at one-year follow-up and associated risk factors. Indian J Ophthalmol 2005; 53: 93-9.
39. Kohner EM. Diabetic retinopathy. Br Med Bull 1989; 45 148-73.
40. Fujisawa T, Ikegami H, Yamato E, Kawaguhi Y, Ueda H, Shintani M, et al. Association of plasma fibrinogen level and blood pressure with diabetic retinopathy and renal complications associated with proliferative diabetic retinopathy in type II diabetes mellitus. Diabet Med 1999; 16: 522-6.
41. Kostraba JN, Klein R, Dorman JS, Becker DJ, Drash AL, Maser RE, et al. The Epidemiology of Diabetes Complications Study. IV. Correlates of diabetic background and proliferative retinopathy. Am J Epidemiol 1991; 133: 381-91.
42. Root HF, Pote WH Jr, Frehner H. Triopathy of diabetes; sequence of neuropathy, retinopathy, and nephropathy in one hundred fifty-five patients. AMA Arch Intern Med 1954; 94: 931-41.
43. Cruickshanks KJ, Ritter LL, Klein R, Moss SE. The association of microalbuminuria with diabetic retinopathy. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. Ophthalmology 1993; 100: 862-7.
44. Klein R, Moss SE, Klein BE. Is gross proteinuria a risk factor for the incidence of proliferative diabetic retinopathy? Ophthalmology 1993; 100: 1140-6.
45. Mathiesen ER, Ronn B, Storm B, Foght H, Deckert T. The natural course of microalbuminuria in insulin-dependent diabetes: a 10-year prospective study. Diabet Med 1995; 12: 482-7.
46. Gupta DK, Verma LK, Khosla PK, Dash SC. The prevalence of microalbuminuria in diabetes: a study from north India. Diabetes Res Clin Pract 1991; 12: 125-8.
47. Singh SK, Behre A, Singh MK. Diabetic retinopathy and microalbuminuria in lean type 2 diabetes mellitus. J Assoc Physicians India 2001; 49: 439-41.
48. Mohan V, Meera R, Premalatha G, Deepa R, Miranda P, Reema M. Frequency of proteinuria in type 2 diabetes mellitus seen at a diabetes centre in southern India. Postgrad Med J 2000; 76: 569-73.
49. Klein R, Zinman B, Gardiner R, Suissa S, Donnelly SM, Sinaiko AR, et al. The relationship of diabetic retinopathy to preclinical diabetic glomerulopathy lesions in type 1 diabetic patients: the Renin-Angiotensin System Study. Diabetes 2005; 54: 527-33.
50. Chew EY, Klein ML, Ferris FL III, Remaley NA, Murphy RF, Chantry K, et al. Association of elevated serum lipid levels with retinal hard exudates in diabetic retinopathy. Early Treatment Diabetic Retinopathy Study (ETDRS) report 22. Arch Ophthalmol 1996; 114: 1079-84.
51. Ferris FL 3rd, Chew KY, Hoogwerf BJ. Serum lipids and diabetic retinopathy. Early Treatment Diabetic Retinopathy Study Research Group. Diabetes Care 1996; 19: 1291-3.
52. Klein BEK, Moss SE, Klein R, Surawicz TS. The Wisconsin Epidemiologic Study of Diabetic Retinopathy, XIII: relationship between serum cholesterol to retinopathy and hard exudate. Ophthalmology 1991; 98: 1261-5.
53. Mohan R, Mohan V, Susheela L, Ramachandran A, Viswanathan M, et al. Increased LDL cholesterol in non-insulin dependent diabetes with maculopathy. Acta Diabetol Lat 1984; 21: 85-9.
54. Sundaram RK, Bhaskar A, Vijayalingam S, Viswanathan M, Rema M, Shanmugasundram KR. Antioxidant status and lipid peroxidation in type II diabetes mellitus with and without complications. Clin Sci 1996; 90: 255-60.
55. Rema M, Srivastava BK, Anitha B, Deepa R, Mohan V. Association of serum lipids with diabetic retinopathy in urban south Indians - The Chennai Urban Rural Epidemiology Study (CURES) Eye Study-2. Diab Med 2005; 23: 1029-36.
56. Diabetes Control and Complications Trial Research Group. Effect of pregnancy on microvascular complications in the diabetes control and complications trial. The Diabetes Control and Complications Trial Research Group. Diabetes Care 2000; 23: 1084-91.
57. Sheth BP. Does pregnancy accelerate the rate of progression of diabetic retinopathy? Curr Diab Rep 2002; 2: 327-30.
58. Chew EY, Mills JL, Metzger BE, Remaley NA, Jovanovic-Peterson L, Knopp RH, et al. Metabolic control and progression of retinopathy. The Diabetes in Early Pregnancy Study. National Institute of Child Health and Human Development Diabetes in Early Pregnancy Study. Diabetes Care 1995; 18: 631-7.
59. Young RJ, McCulloch DK, Prescott RJ, Clarke BF. Alcohol: another risk factor for diabetic retinopathy? Br Med J (Clin Res Ed) 1984; 288: 1035-7.
60. Giuffre G, Lodato G, Dardanoni G. Prevalence and risk factors of diabetic retinopathy in adult and elderly subjects: The Casteldaccia Eye Study. Graefes Arch Clin Exp Ophthalmol 2004; 242: 535-40.
61. Moss SE, Klein R, Klein BE. The association of alcohol consumption with the incidence and progression of diabetic retinopathy. Ophthalmology 1994; 101: 1962-8.
62. Klein R, Klein BE, Moss SE, Davis MD, DeMets DL. Glycosylated hemoglobin predicts the incidence and progression of diabetic retinopathy. JAMA 1988; 260 2864-71.
63. Singh R, Gupta V, Gupta A, Bhansali A. Spontaneous closure of microaneurysms in diabetic retinopathy with treatment of co-existing anaemia. Br J Ophthalmol 2005; 89: 248-9.
64. Davis MD, Fisher MR, Gangnon RE, Barton F, Aiello LM, Chew EY, et al. Risk factors for high-risk proliferative diabetic retinopathy and severe visual loss: Early Treatment Diabetic Retinopathy Study Report #18. Invest Ophthalmol Vis Sci 1998; 39: 233-52.
65. Qiao Q, Keinanen-Kiukaanniemi S, Laara E. The relationship between hemoglobin levels and diabetic retinopathy. J Clin Epidemiol 1997; 50: 153-8.
66. Katusic D, Tomic M, Jukic T, Kordic R, Sikic J, Vukojevic N, et al. Obesity - a risk factor for diabetic retinopathy in type 2 diabetes? Coll Antropol 2005; 29 (Suppl 1): 47-50.
67. van Leiden HA, Dekker JM, Moll AC, Nijpels G, Heine RJ, Bouter LM, et al. Blood pressure, lipids, and obesity are associated with retinopathy: the Hoorn study. Diabetes Care 2002; 25: 1320-5.
68. Zhang L, Krentowski G, Albert A, Lefebvre PJ. Risk of developing retinopathy in Diabetes Control and Complications Trial type 1 diabetic patients with good or poor metabolic control. Diabetes Care 2001; 24: 1275-9.
69. Akiba J, Arzabe CW, Trempe CL. Posterior vitreous detachment and neovascularization in diabetic retinopathy. Ophthalmology 1990; 97: 889-91.
70. Lewis H, Abrams GW, Blumenkranz MS, Campo RV. Vitrectomy for diabetic macular traction and edema associated with posterior hyaloidal traction. Ophthalmology 1992; 99: 753-9.
71. Moss SE, Klein R, Klein BE. Ocular factors in the incidence and progression of diabetic retinopathy. Ophthalmology 1994; 101: 77-83.
72. Schatz H, Atienza D, McDonald HR, Johnson RN. Severe diabetic retinopathy after cataract surgery. Am J Ophthalmol 1994; 117: 314-21.
73. Kim YH, Hong MK, Song JM, Han KH, Kang DH, Song JK, et al. Diabetic retinopathy as a predictor of late clinical events following percutaneous coronary intervention. J Invasive Cardiol 2002; 14: 599-602.
74. Klein BE, Klein R, McBride PE, Cruickshanks KJ, Palta M, Knudtson MD, et al. Cardiovascular disease, mortality, and retinal microvascular characteristics in type 1 diabetes: Wisconsin epidemiologic study of diabetic retinopathy. Arch Intern Med 2004; 164: 1917-24.
75. Rema M, Mohan V, Deepa R, Ravikumar R. Association of carotid intima-media thickness and arterial stiffness with diabetic retinopathy. The Chennai Urban Rural Epidemiology Study (CURES-2). Diabetes Care 2004; 27: 1962-7.
76. Anusha P, Vijayalingam S, Shanmugasundaram R, Rema M. Oxidative stress and the development of diabetic complications - Antioxidants and lipid peroxidation in erythrocytes and cell membrane. Cell Biol Int 1995; 19: 987-93.
77. Rema M, Mohan V, Anusha B, Shanmugasundaram R. Does oxidant stress play a role in diabetic retinopathy. Indian J Ophthalmol 1995; 43: 17-21.
78. Sampathkumar R, Balasubramanyam M, Tara C, Rema M, Mohan V. Association of hypoglutathionemia with reduced Na(+)/K(+) ATPase activity in type 2 diabetes and microangiopathy. Mol Cell Biochem 2006; 282: 169-76.
79. Sampathkumar R, Balasubramanyam M, Sudarslal S, Rema M, Mohan V, Balaram R. Increased glutathionylated hemoglobin (HbSSG) in type 2 diabetes subjects with microangiopathy. Clin Biochem 2005; 38: 892-9.
80. Rema M, Saravanan G, Deepa R. Familial clustering of diabetic retinopathy in South Indian Type 2 diabetic patients. Diabet Med 2002; 19: 910-6.
81. Hallman DM, Huber JC Jr, Gonzalez VH, Klein BE, Klein R, Hanis CL. Familial aggregation of severity of diabetic retinopathy in Mexican Americans from Staff County Texas. Diabetes Care 2005; 28: 1163-8.
82. Viswanath K. Diabetic retinopathy: Clinical findings and management. Commun Eye Health J 2003; 16: 21-4.
83. Bijlsma WR, Stilma JS. Optical coherence tomography, an important new tool in the investigation of the retina. Ned Tijdschr Geneeskd 2005; 149: 1884-91.
84. Sharma S, Brown GC, Brown MM, Hollands H, Shah GK. The cost-effectiveness of grid laser photocoagulation for the treatment of diabetic macular edema: results of a patient-based cost-utility analysis. Curr Opin Ophthalmol 2000; 11: 175-9.
85. Sharma S, Hollands H, Brown GC, Brown MM, Shah GK, Sharma SM, et al. The cost-effectiveness of early vitrectomy for the treatment of vitreous hemorrhage in diabetic retinopathy. Curr Opin Ophthalmol 2001; 12: 230-4.
86. Massin P, Audren F, Haouchine B, et al. Intravitreal triamcinolone acetonide for diabetic diffuse macular edema. Ophthalmology 2004; 11: 218-25.
87. Premanand C, Rema M, Sameer Mahmood Z, Sujatha M, Balasubramanyam M. Effect of curcumin on proliferation of human retinal endothelial cells under in vitro conditions. Invest Ophthalmol Vis Sci 2006; 47: 2179-84.
88. The Early Treatment Diabetic Retinopathy Study Research Group: Effects of aspirin treatment on diabetic retinopathy. ETDRS report number 8. Ophthalmology 1991; 98 (5 Suppl): 757-65.
89. The TIMAD Study Group: Ticlopidine treatment reduces the progression of nonproliferative diabetic retinopathy. Arch Ophthalmol 1990; 108: 1577-83.
90. Arauz-Pacheco C, Ramirez LC, Pruneda L, Sanborn GE, Rosenstock J, Raskin P, et al. The effect of the aldose reductase inhibitor, ponalrestat, on the progression of diabetic retinopathy. J Diabetes Complications 1992; 6 131-7.
91. Van Gerven JM, Boot JP, Lemkes HH. Effects of aldose reductase inhibition with tolrestat on diabetic retinopathy in a six months double blind trial. Doc Ophthalmol 1994; 87: 355-65.
92. Grant MB, Mames RN, Fitzgerald C, Hazariwala KM, Cooper-Dettoff R, Caballero S, et al. The efficacy of octreotide in the therapy of severe nonproliferative and early proliferative diabetic retinopathy: a randomized controlled study. Diabetes Care 2000; 23: 504-9.
93. Chaturvedi N, Sjoelie AK, Svensson A. DIRECT Programme Study Group. The Diabetic Retinopathy Candesartan Trials (DIRECT) Programme, rationale and study design. J Renin Angiotensin Aldosterone Syst 2002; 3: 255-61.
94. ADVANCE Collaborative Group. ADVANCE - Action in diabetes and vascular disease: patient recruitment and characteristics of the study population at baseline. Diabet Med 2005; 22: 882-8.
95. The PKC-DRS Study Group:The effect of Ruboxistaurin on visual loss in patients with moderately severe to very severe nonproliferative diabetic retinopathy: Initial results of the protein kinase C {beta} inhibitor diabetic retinopathy study (PKC-DRS) Multicenter Randomized Clinical Trial. Diabetes 2005; 54: 2188-97.
96. Campochiaro PA. C99-PKC412-003 Study Group. Reduction of diabetic macular edema by oral administration of the kinase inhibitor PKC412. Invest Ophthalmol Vis Sci 2004; 45: 922-31.